Skip to main content
Vijaya Diagnostic Centre Limited logo

Vijaya Diagnostic Centre Limited — Investor Relations & Filings

Ticker · VIJAYA ISIN · INE043W01024 LEI · 33580036Q5DTJTG86994 BSE.NS Human health and social work activities
Open in API
Filings indexed 446 across all filing types
Latest filing 2026-02-13 Board/Management Inform…
Country IN India
Listing BSE.NS VIJAYA

About Vijaya Diagnostic Centre Limited

https://www.vijayadiagnostic.com/

Vijaya Diagnostic Centre Limited provides integrated diagnostic services, encompassing both pathology and radiology. The service portfolio includes a broad spectrum of clinical laboratory tests such as hematology, biochemistry, and molecular diagnostics, complemented by advanced imaging modalities including MRI, CT scans, ultrasound, and digital radiography. The organization operates an extensive network of diagnostic centers equipped with automated systems to ensure precision and efficiency in medical testing. Its offerings serve individual patients, corporate entities, and healthcare institutions. By maintaining rigorous quality control protocols and national accreditations, the company facilitates clinical decision-making through comprehensive diagnostic insights and specialized medical reporting.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Board/Management Information Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Vijaya Diagnostic Centre Limited regarding the outcome of a Board Meeting held on February 13, 2026. It includes multiple items such as approval of unaudited financial results for the third quarter and nine months ended December 31, 2025, appointments and resignations of key managerial personnel (CFO, CTO, COO, and independent directors), grant of employee stock options, and revision of related party transaction policy. The document references compliance with SEBI Listing Regulations and includes annexures with detailed profiles and disclosures related to these appointments and resignations. The content primarily focuses on management changes and corporate governance updates rather than presenting full financial statements or detailed financial analysis. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. The document fits best under the category of Board/Management Information (MANG) because it announces changes in the company's board of directors and senior management, along with related disclosures as required by regulatory authorities.
2026-02-13 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is addressed to stock exchanges with a reference to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating it is a regulatory disclosure. It contains detailed financial results for the third quarter and nine months ended December 31, 2025, including revenue, EBITDA, PAT, operational highlights, and management commentary. The document is 15,000 characters long, which is substantial and contains actual financial data and analysis, not just a summary or announcement. It is explicitly described as a presentation used in an earnings conference call. The content includes forward-looking statements, financial metrics, and strategic updates typical of an investor presentation. Therefore, this document fits the category of an Investor Presentation (IP) rather than an Earnings Release (ER) or Interim Report (IR), as it is a detailed presentation rather than a brief earnings announcement or a comprehensive standalone financial report. Hence, the correct classification is Investor Presentation (IP).
2026-02-13 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the third quarter and nine months of fiscal year 2026. It includes consolidated financial performance data, operational highlights, and management commentary on business outlook. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including financial results. The document is titled as a "Press Release on Financial Results – Q3 FY2026" and contains key financial metrics such as revenue, EBITDA, and profit after tax for the quarter and nine months. It is not a full interim or quarterly report with detailed financial statements but rather an initial announcement of quarterly financial results. Therefore, it fits the definition of an Earnings Release (ER). The document length is 5662 characters, which is sufficient for an earnings release but not a full interim report. Hence, the appropriate classification is ER with high confidence. Q3 2026
2026-02-13 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated February 13, 2026, and contains detailed unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. It references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs quarterly financial results disclosures. The document includes comprehensive financial data such as revenue, expenses, profit before tax, tax expenses, earnings per share, and notes explaining accounting policies and significant events like amalgamation. It also contains a Limited Review Report by the statutory auditors specifically for the quarter and nine months ended December 31, 2025, prepared under Indian Accounting Standard 34 for interim financial reporting. The presence of unaudited quarterly financial results and a limited review report indicates this is an Interim / Quarterly Report. The document is substantive and not merely an announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2026
2026-02-13 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Vijaya Diagnostic Centre Limited dated February 13, 2026. It reports the outcome of a Board Meeting including approval of unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. It also announces multiple appointments and resignations of key management personnel such as CFO, CTO, COO, and independent directors. Additionally, it includes grant of employee stock options and revision of related party transaction policy. The document references SEBI Listing Regulations and includes annexures with detailed profiles and disclosures related to these appointments and resignations. The content primarily concerns changes in senior management and board composition, which fits the category of Board/Management Information (MANG). The document is lengthy (15,000 characters) and contains substantive details, not just a brief announcement or a report publication notice. Therefore, the appropriate classification is MANG with high confidence.
2026-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges about an upcoming earnings conference call scheduled for February 13, 2026, to discuss the financial results for the third quarter and nine months ended December 31, 2025. It includes dial-in details and participant information but does not contain any actual financial data or results. The document is short (4257 characters) and serves as a notification of the call rather than the call transcript or financial report itself. Therefore, it is best classified as a Call Transcript (CT) announcement or related notice. However, since it is only an intimation of the call and not the transcript itself, the closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call. Confidence is high due to clear identification of the document as an earnings call intimation without financial data or transcript.
2026-02-09 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.